278 related articles for article (PubMed ID: 12591985)
1. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells.
Chun KH; Kosmeder JW; Sun S; Pezzuto JM; Lotan R; Hong WK; Lee HY
J Natl Cancer Inst; 2003 Feb; 95(4):291-302. PubMed ID: 12591985
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
Lee HY
Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
[TBL] [Abstract][Full Text] [Related]
3. Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.
Lee HY; Suh YA; Kosmeder JW; Pezzuto JM; Hong WK; Kurie JM
Clin Cancer Res; 2004 Feb; 10(3):1074-9. PubMed ID: 14871987
[TBL] [Abstract][Full Text] [Related]
4. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.
Lee HY; Oh SH; Woo JK; Kim WY; Van Pelt CS; Price RE; Cody D; Tran H; Pezzuto JM; Moriarty RM; Hong WK
J Natl Cancer Inst; 2005 Nov; 97(22):1695-9. PubMed ID: 16288123
[TBL] [Abstract][Full Text] [Related]
6. AKT and the phosphatidylinositol 3-kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment.
Crowell JA; Steele VE
J Natl Cancer Inst; 2003 Feb; 95(4):252-3. PubMed ID: 12591974
[No Abstract] [Full Text] [Related]
7. A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
Kim WY; Chang DJ; Hennessy B; Kang HJ; Yoo J; Han SH; Kim YS; Park HJ; Seo SY; Mills G; Kim KW; Hong WK; Suh YG; Lee HY
Cancer Prev Res (Phila); 2008 Dec; 1(7):577-87. PubMed ID: 19139008
[TBL] [Abstract][Full Text] [Related]
8. [Effects of deguelin on proliferation and apoptosis of MCF-7 breast cancer cells by phosphatidylinositol 3-kinase/Akt signaling pathway].
Chu ZH; Liang XH; Zhou XL; Huang RF; Zhan Qz; Jiang JW
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):533-8. PubMed ID: 21565140
[TBL] [Abstract][Full Text] [Related]
9. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.
Schroeder CP; Kadara H; Lotan D; Woo JK; Lee HY; Hong WK; Lotan R
Cancer Res; 2006 Oct; 66(19):9762-70. PubMed ID: 17018636
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
Krystal GW; Sulanke G; Litz J
Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412
[TBL] [Abstract][Full Text] [Related]
13. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
[TBL] [Abstract][Full Text] [Related]
14. Deguelin exerts anticancer activity of human gastric cancer MGC-803 and MKN-45 cells in vitro.
Kang W; Zheng X; Wang P; Guo S
Int J Mol Med; 2018 Jun; 41(6):3157-3166. PubMed ID: 29512685
[TBL] [Abstract][Full Text] [Related]
15. Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines.
Baba Y; Fujii M; Maeda T; Suzuki A; Yuzawa S; Kato Y
Biomed Res Int; 2015; 2015():657179. PubMed ID: 26075254
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
[TBL] [Abstract][Full Text] [Related]
18. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of deguelin on H460 human lung cancer cells in vitro and in vivo: Roles of apoptotic cell death and H460 tumor xenografts model.
Hsu YC; Chiang JH; Yu CS; Hsia TC; Wu RS; Lien JC; Lai KC; Yu FS; Chung JG
Environ Toxicol; 2017 Jan; 32(1):84-98. PubMed ID: 26592500
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
